Knockdown of PSMA expression promoted cell migration, invasion and EMT in prostate cancer LNCAP cells

doi:10.3969/j.issn.1009-976X.2023.01.010

Lingnan Modern Clinics In Surgery ›› 2023, Vol. 23 ›› Issue (01): 58-63.DOI: 10.3969/j.issn.1009-976X.2023.01.010

• Original Articles and Clinical Research • Previous Articles Next Articles

Knockdown of PSMA expression promoted cell migration, invasion and EMT in prostate cancer LNCAP cells

LI Jin^1,4, LAI Yi-min^2,3,4, ZENG Le-xiang^2,3,4

1. Reproductive Center, Sun Yat Sen Memorial Hospital, Sun Yat Sen University, Guangzhou 510120, China;
2. Urology, Sun Yat Sen Memorial Hospital, Sun Yat Sen University, Guangzhou 510120, China;
3. Guangdong Clinical Medical Research Center for Urinary Diseases, Guangzhou 510120, China;
4. Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangzhou 510120, China

Contact: ZENG Le-xiang, zenglx3@mail.sysu.edu.cn

沉默前列腺特异性膜抗原促进前列腺癌LNCAP细胞上皮-间质转化及迁移、侵袭的研究

李金^1,4, 赖义明^2,3,4, 曾乐祥^2,3

1.中山大学孙逸仙纪念医院生殖中心,广州 510120;
2.中山大学孙逸仙纪念医院泌尿外科,广州 510120;
3.广东省泌尿系统疾病临床医学研究中心,广州 510120;
4.广东省恶性肿瘤表观遗传与基因调控重点实验室,广州 510120

通讯作者: *曾乐祥,Email：zenglx3@mail.sysu.edu.cn
基金资助:
国家自然科学基金资助项目（81802527）; 广东省省级科技计划项目（2021A1515010223）; 白求恩泌尿肿瘤专项研究基金（mnzl202026）; 广东省恶性肿瘤表观遗传与基因调控重点实验室基金（2020B1212060018）; 广东省泌尿系统疾病临床医学研究中心（2020B1111170006）

Abstract

Abstract: Objective To investigate the PSMA expression, migration, invasion and expression of EMT associated proteins in LNCAP cells after transfection of PSMA siRNA. Methods LNCAP cells were cultured and divided into si-PSMA group, negative control siRNA group, inhibitor LY294002 group and LY294002+si-PSMA group. The expressions of PSMA mRNA and protein were detected respectively by qRT-PCR and Western blot. Transwell assay were used to detect migration and invasion in LNCAP cells.Western blot was used to detect the effect of PSMA inhibitionon the protein expression of p-Akt （ser473） and epithelial mesenchymal transformation marker proteins such as E-cadherin, β-cadherin, vimentin and snail. Results Compared with negative control group, the mRNA and protein expression of PSMAin LNCAP cells was downregulated by transfection of PSMAsiRNA（P<0.05）. Transwell results showed that the migration and invasion rates were increased in si-PSMA group（P<0.05） and decreased in LY294002 group,but was rescued combined with siRNA（P<0.05）. Western blot results displayed higher expression of vimentin, snail and p-Akt（ser473） while lower expression of E-cadherin and β-cadherin in si-PSMA group. Conclusion Knockdown of PSMA may promote the migration and invasion of LNCAP cells by activating epithelial mesenchymal transformation pathway.

Key words: PSMA, prostate cancer, EMT

摘要： 目的利用RNAi技术沉默LNCAP细胞中前列腺特异性膜抗原（PSMA）表达并检测表达情况,检测沉默PSMA后LNCAP细胞迁移及侵袭等生物学行为的变化情况,以及LNCAP细胞中上皮-间质转化标志蛋白的变化情况。方法培养LNCAP细胞,分为si-PSMA组,阴性对照（negative control siRNA）组,抑制剂LY294002组和LY294002+si-PSMA组,采用qRT-PCR 和Western blot技术检测沉默PSMA后LNCAP细胞中PSMA的mRNA和蛋白表达情况,通过Transwell小室穿透实验检测LNCAP细胞迁移及侵袭能力改变,通过Western blot蛋白印迹法检测E-cadherin、β-cadherin、vimentin,snail等细胞上皮-间质转化标志蛋白的表达情况以及p-Akt（ser473）蛋白表达情况。结果与阴性对照组相比,si-PSMA组PSMA的mRNA和蛋白表达水平都明显降低（P<0.05）,Transwell结果显示迁移及侵袭细胞增多（P<0.01）,LY294002组细胞迁移及侵袭下调（P<0.05）,而LY294002+si-RNA组则可逆转下降趋势（P<0.05）,Western blot结果显示E-cadherin与β-cadherin的表达减弱,而vimentin、snail和p-Akt（ser473）的表达增强。结论沉默PSMA可能通过激活上皮间质化通路促进前列腺癌细胞迁移及侵袭能力。

关键词: 前列腺特异性抗原蛋白, 前列腺癌, 上皮-间质转化

CLC Number:

R737.25

LI Jin, LAI Yi-min, ZENG Le-xiang. Knockdown of PSMA expression promoted cell migration, invasion and EMT in prostate cancer LNCAP cells[J]. Lingnan Modern Clinics In Surgery, 2023, 23(01): 58-63.

李金, 赖义明, 曾乐祥. 沉默前列腺特异性膜抗原促进前列腺癌LNCAP细胞上皮-间质转化及迁移、侵袭的研究[J]. 岭南现代临床外科, 2023, 23(01): 58-63.

References

[1] Sheehan B, Guo C, Neeb A, et al.Prostate-specific Membrane Antigen Biology in Lethal Prostate Cancer and its Therapeutic Implications[J]. Eur Urol Focus, 2022, 8(5):1157-1168.
[2] Rahn KA, Watkins CC, Alt J, et al.Inhibition of glutamate carboxypeptidase II (GCPII) activity as a treatment for cognitive impairment in multiple sclerosis[J]. Proc Natl Acad Sci U S A, 2012, 109(49): 20101-20106.
[3] Paschalis A, Sheehan B, Riisnaes R, et al.Prostate-specific Membrane Antigen Heterogeneity and DNA Repair Defects in Prostate Cancer[J]. Eur Urol, 2019, 76(4): 469-478.
[4] Ristau BT, O'Keefe DS, Bacich DJ. The prostate-specific membrane antigen: lessons and current clinical implications from 20 years of research[J]. Urol Oncol, 2014, 32(3): 272-279.
[5] Ghosh A, Wang X, Klein E, et al.Novel role of prostate-specific membrane antigen in suppressing prostate cancer invasiveness[J]. Cancer Res, 2005, 65(3): 727-731.
[6] Guo Z, Huang H, Zeng L, et al.Lentivirus-mediated RNAi knockdown of prostate-specific membrane antigen suppresses growth, reduces migration ability and the invasiveness of prostate cancer cells[J]. Med Oncol, 2011, 28(3): 878-887.
[7] Yang J, Antin P, Berx G, et al.Author Correction: Guidelines and definitions for research on epithelial-mesenchymal transition[J]. Nat Rev Mol Cell Biol, 2021, 22(12): 834.
[8] Siegel R L, Miller K D, Fuchs H E, et al.Cancer Statistics, 2021[J]. CA Cancer J Clin, 2021, 71(1): 7-33.
[9] Belkahla S, Nahvi I, Biswas S, et al.Advances and development of prostate cancer, treatment, and strategies: A systemic review[J]. Front Cell Dev Biol, 2022, 10:991330.
[10] 王铸, 曹开源, 何霞, 等. PSMA基因沉默的前列腺癌细胞中肿瘤转移相关基因表达的芯片分析[J].中国病理生理杂志, 2012, 28(6): 980-984.
[11] 曹开源, 张甜, 徐霖, 等. RNAi沉默PSMA基因对前列腺癌LNCaP细胞生物学行为的影响[J].中国病理生理杂志, 2008(10): 1877-1881.
[12] Colombatti M, Grasso S, Porzia A, et al.The prostate specific membrane antigen regulates the expression of IL-6 and CCL5 in prostate tumour cells by activating the MAPK pathways[J]. PLoS One, 2009, 4(2): e4608.
[13] Lu W, Kang Y.Epithelial-Mesenchymal Plasticity in Cancer Progression and Metastasis[J]. Dev Cell, 2019, 49(3): 361-374.
[14] Dongre A, Weinberg RA.New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer[J]. Nat Rev Mol Cell Biol, 2019, 20(2): 69-84.
[15] Tsai PJ, Lai YH, Manne RK, et al.Akt: a key transducer in cancer[J]. J Biomed Sci, 2022, 29(1): 76.
[16] Khezri MR, Jafari R, Yousefi K, et al.The PI3K/AKT signaling pathway in cancer: Molecular mechanisms and possible therapeutic interventions[J]. Exp Mol Pathol, 2022, 127:104787.
[17] Fedorova O, Parfenyev S, Daks A, et al.The Role of PTEN in Epithelial-Mesenchymal Transition[J]. Cancers, 2022, 14(15): 3786.

Knockdown of PSMA expression promoted cell migration, invasion and EMT in prostate cancer LNCAP cells

沉默前列腺特异性膜抗原促进前列腺癌LNCAP细胞上皮-间质转化及迁移、侵袭的研究

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

[1]	LI Jin, LI Ling-feng, LAI Yi-ming. Analysis of the expression and significance of GPX4 in prostate cancer based on database mining [J]. Lingnan Modern Clinics In Surgery, 2022, 22(05): 503-508.
[2]	SONG Hong-wen, WANG Ji-xin, Asimujiang Abula, Wang Yu-jie, WANG Wen-guang. Analysis of influencing factors of Gleason grade upgrading after radical prostatectomy（Based on 2014 ISUP grouping） [J]. Lingnan Modern Clinics In Surgery, 2022, 22(04): 378-383.
[3]	CHEN Xiu-feng, BU Qing-feng, ZHANG Jie. The predictive value of PI-RADS v2 based on multi-parameter magnetic resonance imaging combined with f/t PSA and PSAD in prostate cancer [J]. Lingnan Modern Clinics In Surgery, 2021, 21(02): 213-216.
[4]	CHEN Mei-xian, YANG Xue-ying, LIAO Zhao-xia, YE Xi-jiu, LU Fu-ding. Application of deep neuromuscular blocking in obese patients undergoing robot-assisted laparoscopic radical prostatectomy [J]. Lingnan Modern Clinics in Surgery, 2020, 20(04): 468-471.
[5]	YUAN Xiao-xu, QIU Jian-guang, ZHU Yu-mo, LIN Xuehua, PANG Guo-fu, DENG Jian, XIE Qun. Transperineal prostate biopsy and transrectal prostate biopsy in the diagnosis of prostate cancer [J]. Lingnan Modern Clinics in Surgery, 2020, 20(04): 484-487.
[6]	TAN Ying, LIAN Guo-da, CHEN Shao-jie, LI Jia-jia, CHEN Shang-xiang, HUANG Kai-hong, CHEN Yin-ting. Expression level and prognostic significance of TIMP1 and EFEMP1 in rectal cancer [J]. Lingnan Modern Clinics in Surgery, 2020, 20(02): 161-166.
[7]	HU Lijuan， DAI Qishan， HU Jianbo. A clinical study of 89Sr， zoledronic acid and 99Tc?MDP on the eldly patients with bone metastases of prostate cancer [J]. Lingnan Modern Clinics in Surgery, 2019, 19(04): 437-446.
[8]	HU Lijuan， DAI Qishan， HU Jianbo. A clinical study of abiraterone combined with prednisone for treating elderly metastatic castration?resistant prostate cancer [J]. Lingnan Modern Clinics in Surgery, 2019, 19(03): 333-336.
[9]	YOU Hongke， WEN Bo， YIN Yonghua. The expression of deubiquitinase 3 in prostate cancer and its effect on biological phenotypes of prostate cancer cells [J]. Lingnan Modern Clinics in Surgery, 2019, 19(03): 337-340.
[10]	YE Xiuqin， DING Zhimin， DONG Fajin， WEI Zhanghong， LIU Huiyu， WU Huaiyu， XU Jinfeng. The value of transrectal real?time elastography?targeted biopsy in the detection and diagnosis of prostate lesion [J]. Lingnan Modern Clinics in Surgery, 2019, 19(02): 195-198.
[11]	LIN Chunhao, LAI Yiming, PENG Shengmeng, HUANG Hai, GUO Zhenghui.. Expression and clinical significance of Polo?like kinase 3 in prostate cancer [J]. Lingnan Modern Clinics in Surgery, 2018, 18(02): 133-136.
[12]	WEI Xinghua, Lin Yurong, YANG Wenjun, XIE Keji, TANG Ping. Significance of PSA density for detecting prostate cancer in Paients with a PSA between 2.5-10.0 ng/ml and 10.1-20.0 ng/ml:a multicenter study [J]. Lingnan Modern Clinics in Surgery, 2016, 16(03): 327-330.
[13]	XIAO Congqin, HU Jianbo, ZHOU Yinan. Study of genistein on inducing apoptosis in prostate cancer DU-145 cells [J]. Lingnan Modern Clinics in Surgery, 2016, 16(02): 215-218.
[14]	WAN Yueping, XI Ming, WAN Song, HUA Wei, ZENG ZhaoChang, LIU Yuanling, LIN Zhuoyuan, WU Yongding, YANG Shengbang, HAN Zhaodong. Increased expression of tribbles pseudokinase 1 (TRIB1) mRNA and protein predicts malignant progression and adverse clinical outcomes in patients with prostate cancer [J]. Lingnan Modern Clinics in Surgery, 2016, 16(01): 87-91.
[15]	Cai Canfeng, Tang Chaomin, Zeng Jun, Chen Guoxing, Chen Xiang, Liang Min, . GLUD1 promotes migration and invasion of colorectal cancer cells via epithelial-mesenchymal transition (EMT) [J]. Lingnan Modern Clinics in Surgery, 2015, 15(04): 456-460.